It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acinetobacter baumannii and Klebsiella pneumoniae are opportunistic pathogens frequently co-isolated from polymicrobial infections. The infections where these pathogens co-exist can be more severe and recalcitrant to therapy than infections caused by either species alone, however there is a lack of knowledge on their potential synergistic interactions. In this study we characterise the genomes of A. baumannii and K. pneumoniae strains co-isolated from a single human lung infection. We examine various aspects of their interactions through transcriptomic, phenomic and phenotypic assays that form a basis for understanding their effects on antimicrobial resistance and virulence during co-infection. Using co-culturing and analyses of secreted metabolites, we discover the ability of K. pneumoniae to cross-feed A. baumannii by-products of sugar fermentation. Minimum inhibitory concentration testing of mono- and co-cultures reveals the ability for A. baumannii to cross-protect K. pneumoniae against the cephalosporin, cefotaxime. Our study demonstrates distinct syntrophic interactions occur between A. baumannii and K. pneumoniae, helping to elucidate the basis for their co-existence in polymicrobial infections.
Here, the authors characterise Acinetobacter baumanii and Klebsiella pneumoniae isolated from a single human lung infection and proceed to define their interactions to shed light on how this impacts their evolution, growth parameters, metabolism and antimicrobial responses.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Cain, Amy K. 1
; Dawson, Catherine J. 2
; Liu, Qi 3 ; Dinh, Hue 1
; Lott, Hannah 3 ; Penesyan, Anahit 1
; Maharjan, Ram 1 ; Short, Francesca L. 4
; Hassan, Karl A. 5
; Paulsen, Ian T. 1
1 Macquarie University, ARC Centre of Excellence in Synthetic Biology, School of Natural Sciences, North Ryde, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); Macquarie University, School of Natural Sciences, North Ryde, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405)
2 University of Newcastle, School of Environmental and Life Sciences, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)
3 Macquarie University, School of Natural Sciences, North Ryde, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405)
4 Monash University, Department of Microbiology, Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
5 Macquarie University, ARC Centre of Excellence in Synthetic Biology, School of Natural Sciences, North Ryde, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); University of Newcastle, School of Environmental and Life Sciences, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)




